Redefining the Normal: Ultra-High Frequency Ultrasound Characterization of Lymphatic Anatomy in Patients With Breast Cancer
Status: Recruiting
Location: See location...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a prospective pilot study of breast cancer patients undergoing axillary lymph node dissection (ALND) or sentinel lymph node biopsy (SLNB). Participants will undergo ultra-high frequency ultrasound (UHFUS) imaging with indocyanine green (ICG) dye to map lymphatic channels between the wrist and elbow to investigate normal lymphatic anatomy in patients with breast cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• 1\. Aged 18+ at the time of consent.
• 2\. Confirmed breast cancer diagnosis
• 3\. Planned ALND (CPT code: 38745) or SLNB (CPT code: 38900) for breast cancer treatment
• 4\. Provision of a signed and dated informed consent form.
• 5\. Stated willingness to comply with all study procedures and availability for the duration of the study.
Locations
United States
California
University of California Davis Health
RECRUITING
Sacramento
Contact Information
Primary
Sheri Nichols
slnichols@health.ucdavis.edu
(916) 734-7289
Time Frame
Start Date: 2026-06-17
Estimated Completion Date: 2036-09-01
Participants
Target number of participants: 50
Treatments
Experimental: Ultra-high frequency ultrasound (UHFUS) imaging with indocyanine green (ICG) dye
Indocyanine green (ICG) solution will be injected intradermally, followed by ultra-high-frequency ultrasound imaging/mapping to characterize lymphatic channels.
Related Therapeutic Areas
Sponsors
Leads: University of California, Davis